Steinmaus, Craig ORCID: https://orcid.org/0000-0003-2697-843X, Bates, Michael N., Yuan, Yan, Kalman, Dave, Atallah, Raja, Rey, Omar A.
ORCID: https://orcid.org/0000-0002-9232-1252, Biggs, Mary Lou, Hopenhayn, Claudia, Moore, Lee E., Hoang, Bruce K. and Smith, Allan H.
(2006)
Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States.
Journal of Occupational and Environmental Medicine, 48 (5).
pp. 478-488.
ISSN 1076-2752
![]() |
PDF
- Otro
Disponible bajo Licencia CC Atribución-NoComercial-SinDerivadas 4.0 Internacional. Descargar (66kB) |
Resumen
Objective: We sought to assess whether the metabolism of arsenic impacts a person's susceptibility to bladder cancer. Methods: Urinary methylation products were measured in subjects from Argentina (114 cases and 114 controls) and the United States (23 cases and 49 controls). Results: In Argentina, the adjusted odds ratio (OR) for subjects with a high proportion of ingested arsenic excreted as monomethylarsonate (%MMA) was 2.17 (95% confidence interval [CI] = 1.02-4.63) in smokers and 0.48 (95% CI = 0.17-1.33) in nonsmokers. In the United States, the adjusted ORs for high %MMA in subjects with arsenic intakes less than and greater than 100 μg/d were 1.20 (95% CI = 0.27-5.38) and 2.70 (95% CI = 0.39-18.6). Conclusions: Overall, these results are consistent with data from Taiwan suggesting that some individuals who excrete a higher proportion of ingested arsenic as MMA are more susceptible to arsenic-related cancer.
Tipo de documento: | Artículo |
---|---|
DOI: | https://doi.org/10.1097/01.jom.0000200982.28276.70 |
Palabras clave: | Aged. Arsenic. Case-Control Studies. Methylation. Middle Aged. Odds Ratio. United States. Urinary Bladder Neoplasms. |
Temas: | R Medicina > R Medicina (General) |
Unidad académica: | Universidad Católica de Córdoba > Facultad de Ciencias de la Salud |
Google Académico: | |
URI: | http://pa.bibdigital.ucc.edu.ar/id/eprint/4002 |
![]() |
Editar ítem |